Expression of topoisomerase II and Ki-67 in cervical carcinoma - Clinicopathological study using immunohistochemistry

APMIS

Volumn 108, Issue 3, 2000, Pages 209-215

  Davidson, Ben ^a   Goldberg, Iris ^a   Lerner Geva, Liat ^a   Gotlieb, Walter H ^a   Ben Baruch, Gilad ^a   Novikov, Ilya ^a   Kopolovic, Juri ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cervical intraepithelial neoplasia; Ki 67; Patient survival; Squamous cell carcinoma; Topoisomerase II; Uterine cervix

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); KI 67 ANTIGEN;

ADULT; AGE; ANTIBODY DETECTION; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA TOPOISOMERASES, TYPE II; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; SURVIVORS; UTERINE CERVICAL NEOPLASMS;

EID: 0034099891     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2000.d01-46.x     Document Type: Article

References (36)

1. 1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 1995;87:796-802.
2. 2. Johnson LD, Nickerson RJ, Easterday CL, Stuart RS, Hertig AT. Epidemiologie evidence for the spectrum of change from dysplasia through carcinoma in situ to invasive cancer. Cancer 1968;22:901-14.
3. 3. Kosary CL. FIGO stage, histology, histologie grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-1987 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 1994;10:31-46.
4. 4. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki67. Am J Pathol 1991;138:867-73.
5. 5. Cattoretti G, Becker MHG, Key G, Duchrow M, Schlueter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
6. 6. McCluggage WG, Maxwell P, Bharucha H. Immunohistochemical detection of metallothionein and MIB1 in uterine cervical squamous lesions. Int J Gynecol Pathol 1998;17:29-35.
7. 7. Hietala KA, Kosma VM, Syrjanen KJ, Syrjanen SM, Kellokoski JK. Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia. J Pathol 1997;183:305-10.
8. 8. Gibbons D, Fogt F, Kasznica J, Holden J, Nikulasson S. Comparison of topoisomerase II alpha and MIB-1 expression in uterine cervical squamous lesions. Mod Pathol 1997;10:409-13.
9. 9. al-Saleh W, Delvenne P, van den Brule FA, Menard S, Boniver J, Castronovo V. Expression of the 67 KD laminin receptor in human cervical pre-neoplastic and neoplastic squamous epithelial lesions: an immunohistochemical study. J Pathol 1997;181:287-93.
10. 10. Dunton CJ, van Hoeven KH, Kovatich AJ, Oliver RE, Scacheri RQ, Cater JR, et al. Ki-67 antigen staining as an adjunct to identifying cervical intraepithelial neoplasia. Gynecol Oncol 1997; 64:451-55.
11. 11. Payne S, Kernohan NM, Walker F. Proliferation in the normal cervix and in preinvasive cervical lesions. J Clin Pathol 1996;49:667-71.
12. 12. al-Saleh W, Delvenne P, Greimers R, Fridman V, Doyen J, Boniver J. Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with the histologie grade and human papillomavirus type. Am J Clin Pathol 1995;104:154-60.
13. 13. Dellas A, Schultheiss E, Holzgreve W, Oberholzer M, Torhorst J, Gudat F. Investigation of the Bcl-2 and C-myc expression in relationship to the Ki-67 labelling index in cervical intraepithelial neoplasia. Int J Gynecol Pathol 1997;16:212-8.
14. 14. ter Harmsel B, Kuijpers J, Smedts F, Jeunink M, Trimbos B, Ramaekers F. Progressing imbalance between proliferation and apoptosis with increasing severity of cervical intraepithelial neoplasia. Int J Gynecol Pathol 1997;16:205-11.
15. 15. Bulten J, van der Laak JA, Gemmink JH, Pahlplatz MM, de Wilde PC, Hanselaar AG. MIB1, a promising marker for the classification of cervical intraepithelial neoplasia. J Pathol 1996;178:268-73.
16. 16. Isacson C, Kessis TD, Hedrick L, Cho KR. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res 1996;56:669-74.
17. 17. Mittal K, Palazzo J. Cervical condylomas show higher proliferation than do inflamed or metaplastic cervical squamous epithelium. Mod Pathol 1998;11:780-3.
18. 18. Cina SJ, Richardson MS, Austin RM, Kurman RJ. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 1997;10:176-80.
19. 19. van Hoeven KH, Ramondetta L, Kovatich AJ, Bibbo M, Dunton J. Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endocervical lesions. Int J Gynecol Pathol 1997;16:15-21.
20. 20. Avall-Lundquist EH, Silfversward C, Aspenblad U, Nilsson BR, Auer GU. The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma. Eur J Cancer 1997;33:1799-804.
21. 21. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, de Nictolis M, Muzzioli M, et al. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity. Gynecol Oncol 1995;58:28-33.
22. 22. Oka K, Arai T. MIB1 growth fraction is not related to prognosis in cervical squamous cell carcinoma treated with radiotherapy. Int J Gynecol Pathol 1996;15:23-7.
23. 23. Nakano T, Oka K. Differential values of Ki-67 and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer. Cancer 1993;72:2401-8.
24. 24. Berger GM. Type II DNA topoisomerases. Curr Opin Struct Biol 1998;8:26-32.
25. 25. Kaufmann WK. Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints. Proc Soc Exp Biol Med 1998;217: 327-34.
26. 26. McLeod HL, Douglas F, Oates M, Symonds RP, Prakash D, van der Zee AGJ, et al. Topoisomerase I and II activity in human breast, cervix, lung and colon cancer. Int J Cancer 1994;59:607-11.
27. 27. Look KY, Blessing JA, Levenback C, Kohler M, Chafe W, Roman LD. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology study group. Gynecol Oncol 1998;70:334-8.
28. 28. Rosai J. FIGO staging for carcinoma of the cervix uteri. In: Rosai J, editor. Ackerman's Surgical Pathology. Mosby; 1996, 1367.
29. 29. Giorno R. A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn Immunol 1984;2:161-6.
30. 30. Guesdon JL, Ternynck T, Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979;27: 1131-9.
31. 31. Devictor B, Bonnier P, Piana L, Andrac L, Lavaut MN, Allasia C, et al. C-myc protein and Ki-67 antigen immunodetection in patients with uterine cervical neoplasia: correlation with microcytophotometric analysis and histological data. Gynecol Oncol 1993;49:284-90.
32. 32. Shoji Y, Saegusa M, Takano Y, Ohbu M, Okayasu I. Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinomas. J Clin Pathol 1996;49: 134-8.
33. 33. McCluggage WG, Maxwell P, McBride HA, Hamilton PW, Bharucha H. Monoclonal antibodies Ki-67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material. Int J Gynecol Pathol 1995;14:209-16.
34. 34. Davidson B, Goldberg I, Gotlieb WH, Lerner Geva L, Ben Baruch G, Kopolovic J. Ulex Europaeus lectin and anti-CD31 staining in squamous cell carcinoma of the uterine cervix: potentical prognostic markers. Int J Gynecol Pathol 1998;17:205-10.
35. 35. Davidson B, Goldberg I, Kopolovic J, Lerner Geva L, Gotlieb WH, Ben Baruch G, Reich R. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma - a clinico-pathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 1999;73:372-82.
36. 36. Nuovo GJ, MacConnel PB, Simsir A, Valea F, French DL. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 1995;55:267-75.